| P50 | author | John Pernow | Q55414577 |
| | Ilonka Rohm | Q88046222 |
| | Bernhard Wernly | Q88151787 |
| | Christian Jung | Q89633583 |
| | Janne Cadamuro | Q90654597 |
| | Christiana Schernthaner | Q91677771 |
| | Rudin Pistulli | Q93190156 |
| | Elisabeth Haschke-Becher | Q110853911 |
| | Daniel Kretzschmar | Q114309449 |
| | Uta C. Hoppe | Q114309454 |
| | Paul Christian Schulze | Q114309463 |
| | Vera Paar | Q114309466 |
| | Michael Lichtenauer | Q38642727 |
| P2093 | author name string | Attila Yilmaz | |
| | Hans-Reiner Figulla | |
| P2860 | cites work | Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. | Q43470860 |
| | Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome | Q43715189 |
| | Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction | Q44245130 |
| | Human Heart-Type Fatty Acid-Binding Protein as an Early Diagnostic and Prognostic Marker in Acute Coronary Syndrome | Q44414818 |
| | Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions | Q45086910 |
| | Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure. | Q50763149 |
| | Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction. | Q50933676 |
| | Heart-type fatty acid-binding protein as a diagnostic biochemical marker for early detection of myocardial infarction. | Q51439812 |
| | High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin | Q56490134 |
| | Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome | Q56593478 |
| | IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines | Q24294720 |
| | MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily | Q24317134 |
| | Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial | Q28253329 |
| | Structure of human urokinase plasminogen activator in complex with its receptor | Q28295335 |
| | Heart type fatty acid binding protein: structure, function and biosensing applications for early detection of myocardial infarction | Q30426435 |
| | The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury | Q33231048 |
| | Correlation of heart-type fatty acid–binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk | Q33651947 |
| | Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY | Q33942064 |
| | A catalogue of reporting guidelines for health research | Q34091472 |
| | Recruitment of circulating dendritic cell precursors into the infarcted myocardium and pro-inflammatory response in acute myocardial infarction | Q34228722 |
| | Third universal definition of myocardial infarction | Q34295914 |
| | The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study | Q35574948 |
| | Fetuin-A is related to infarct size, left ventricular function and remodelling after acute STEMI. | Q35809242 |
| | Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study | Q36779000 |
| | Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts | Q36796387 |
| | Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction | Q36864318 |
| | Multimarker Risk Stratification in Patients With Acute Myocardial Infarction | Q36956650 |
| | Targeting inflammatory pathways in myocardial infarction. | Q37100838 |
| | Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials | Q37584696 |
| | ST2: a novel biomarker for heart failure | Q37750852 |
| | Growth differentiation factor 15 in heart failure: an update | Q38041973 |
| | A novel cardiac bio-marker: ST2: a review. | Q38171069 |
| | Novel biomarkers predicting cardiac function after acute myocardial infarction | Q38841682 |
| | Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. | Q40078898 |
| | Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure | Q41624837 |
| | A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor | Q42834513 |
| | The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes | Q42943900 |
| | Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI. | Q43141034 |
| | Early diagnosis of myocardial infarction with sensitive cardiac troponin assays | Q43285257 |
| P433 | issue | 9 | |
| P304 | page(s) | 638-648 | |
| P577 | publication date | 2017-07-06 | |
| P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
| P1476 | title | Multibiomarker analysis in patients with acute myocardial infarction | |
| P478 | volume | 47 | |